Many novel treatments are emerging in MOGAD that can help accelerate recovery from attacks and prevent future relapses leading to a lot of hope for improved outcomes in the future for those with MOGAD.
Coming Soon
Eoin P. Flanagan, MB, BCh
Professor of Neurology and Chair of the Division of MS and Autoimmune Neurology, Mayo Clinic, Rochester, MN.
The Patient Health Alliance (PHA) is a source of information and education for NMOSD and related conditions. The content of the following presentation is based entirely on published data or expert opinion. PHA is not a clinical provider, and does not offer diagnostic, therapeutic or clinical care recommendations or advice on personal health. All patients and caregivers are advised to consult with their healthcare team for specific information.